Allergy Diagnostics and Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Test (In vitro, In vivo); By Product; By Drug Class; By End-Use; By Region; Segment Forecast, 2021 - 2028
- Published Date:Sep-2021
- Pages: 118
- Format: PDF
- Report ID: PM1334
- Base Year: 2020
- Historical Data: 2016-2019
Report Outlook
The global allergy diagnostics and therapeutics market size was valued at USD 4.87 billion in 2020 and is expected to grow at a CAGR of 11.0% during the forecast period. Allergy diagnostics include tests to determine the body’s hypersensitivity towards allergens such as dust, drug, food, and insects, among others.
Know more about this report: request for sample pages
Therapeutics are prescribed to patients with allergies to remediate the associated effects. Allergies can cause severe consequences to the lungs, skin, and gastrointestinal tract. The market demand for allergy therapeutics has increased over the years owing to the rising population and growing environmental pollution.
The global market for allergy diagnostics and therapeutics is driven by increasing incidences of allergies and rising healthcare expenditure. The healthcare industry worldwide is attracting significant investments to improve infrastructure and develop technologically advanced allergy diagnostics.
The allergy therapeutics industry has been impacted by the outbreak of COVID-19 due to lockdown, restriction on movement, reduced workforce, and operational challenges across the globe. Numerous research studies suggest increased risks of COVID-19 due to allergies.
With the pandemic requiring the focus of the healthcare workers, the allergy and immunology department experienced a delay for patient care during the pandemic. There has been increasing adoption of telehealth solutions and virtual care for severe cases owing to the greater need to maintain social distancing.
Know more about this report: request for sample pages
Industry Dynamics
Growth Drivers
The growing industrialization, urbanization, changing consumer lifestyles, poor nutrition, and rise in greenhouse emissions have increased the number of cases associated with allergies, further supporting the adoption of allergy therapeutics.
The growing adoption of in vitro diagnostic tests, improvement in medical insurance policies, and growing demand from the developing countries are some other factors fueling the therapeutics market growth. Governments across the globe are introducing strict healthcare regulations and awareness campaigns, encouraging market players to develop practical and patient-friendly tests.
The different types of tests performed to identify allergies include skin prick tests, intradermal skin tests, blood tests, and patch tests, among others. The skin prick test is the most used method performed to determine the potential causes of allergy. It is a cost-effective and simple test to test a wide range of allergens with immediate response.
This method is utilized with allergens that cause asthma, eczema, rhinitis, and conjunctivitis, among others. A patch test is performed for suspected allergen with delayed response. It is used with allergens that take a few days to respond, such as contact dermatitis.
Report Segmentation
The market is primarily segmented on the basis of test, product, drug class, end-use, and region.
|
By Test |
By Product |
By Drug Class |
By End-User |
By Region |
|
|
|
|
|
Know more about this report: request for sample pages
Test Outlook
On the basis of the test, the therapeutics market is segmented into in vitro and in vivo. There has been a high demand for in vivo tests. The increasing need for efficient, quick, and easy-to-use testing solutions has increased the demand for in vivo diagnostic tests. These tests analyze the reactivity and sensitivity of dermal mast cells to reflect allergic sensitivity. These tests include skin tests with standardized allergenic extracts to offer reliability.
Product Outlook
The product segment has been divided into consumables, instruments, and services. The consumables segment accounted for a significant share of the global market for allergy therapeutics in 2020.
Consumables are useful tools for the accurate diagnosis and treatment of allergies. They offer low-cost and straightforward screening methods and high analytical performance. An increasing need for higher efficiency and effective allergy therapeutics has been observed, driving the growth of this market segment.
Drug Class Outlook
The drug class segment has been divided into corticosteroids, antihistamines, leukotriene inhibitors, decongestants, nasal anticholinergics, and others. The antihistamines segment dominated the global therapeutics market in 2020.
Antihistamines are utilized to treat symptoms of allergies. Antihistamines work by reducing or blocking histamines produced through contact with allergens. They are available in different forms such as tablets, capsules, liquids, nasal sprays, and eye drops.
End-Use Outlook
Based on end-use, the market for allergy therapeutics is segmented into hospitals, diagnostics labs, research and development centers, and others. The diagnostics labs segment dominated the global market for allergy therapeutics in 2020.
The high traffic environment, advanced healthcare infrastructure, availability of specialized medical devices, and presence of experienced medical professionals in diagnostic labs support the growth of this segment. Diagnostics labs offer accurate diagnoses using advanced screening techniques and use of immunoassay tests in allergy diagnosis.
Regional Outlook
North America dominated the global allergy diagnostics and therapeutics market in 2020. Increasing cases of respiratory disorders, growing research and development activities, and technological advancements are some factors attributed to the growth of allergy diagnostics and therapeutics in this region.
Changing lifestyles and the increasing geriatric population have increased the demand for allergy diagnostics and therapeutics in the region. The established healthcare infrastructure, growing adoption of in vitro tests, and growing investments in clinical trials further accelerate the advancements in allergy diagnostics and therapeutics.
Competitive Landscape
The leading market players in the allergy diagnostics and therapeutics market include ACON Laboratories, Inc., AESKU.GROUP GmbH, Astra Biotech GmbH, bioMérieux SA, Danaher, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HOB Biotech Group Corp., Ltd., HollisterStier Allergy, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., NEOGEN Corporation, Omega Diagnostics Group PLC, R-Biopharm AG, Romer Labs Division Holding, Siemens Healthineers, Stallergenes Greer, Thermo Fisher Scientific Inc.
These players are expanding their presence across various geographies and entering new markets in developing regions to expand their customer base and strengthen their presence in the therapeutics market. The companies are also introducing new innovative products in the market to cater to the growing consumer demands.
Allergy Diagnostics and Therapeutics Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2020 |
USD 4.87 billion |
|
Revenue forecast in 2028 |
USD 9.93 billion |
|
CAGR |
11.0% from 2021 - 2028 |
|
Base year |
2020 |
|
Historical data |
2016 - 2019 |
|
Forecast period |
2021 - 2028 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2021 to 2028 |
|
Segments covered |
By Test, By Product, By Drug Class, By End-Use, By Region |
|
Regional scope |
North America Europe Asia Pacific Latin America; Middle East & Africa |
|
Key Companies |
ACON Laboratories, Inc., AESKU.GROUP GmbH, Astra Biotech GmbH, bioMérieux SA, Danaher, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HOB Biotech Group Corp., Ltd., HollisterStier Allergy, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., NEOGEN Corporation, Omega Diagnostics Group PLC, R-Biopharm AG, Romer Labs Division Holding, Siemens Healthineers, Stallergenes Greer, Thermo Fisher Scientific Inc. |
© 2024 Polaris Market Research and Consulting. All rights reserved
